Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

matching

matching is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 157
News articles 0
Drug details — matching
Class
—
Route
—
Patents
20
Programs
157
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

matching is an FDA-listed pharmaceutical active ingredient.

Key facts

INN matching

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. 1245-0256 Phase 3 · Boehringer Ingelheim · Chronic kidney disease in paediatric patients
  2. 1305-0023 Phase 3 · Boehringer Ingelheim · Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
  3. 1305-0046 Phase 3 · Boehringer Ingelheim · Systemic Autoimmune Rheumatic Diseases associated Interstiti
  4. 1305-0069 Phase 3 · Boehringer Ingelheim · Interstitial lung diseases, Familial pulmonary fibrosis, Pul
  5. 1378-0018 Phase 3 · Boehringer Ingelheim · Heart failure
  6. 1378-0020 Phase 3 · Boehringer Ingelheim · Heart failure (HF)
  7. 1378-0041 Phase 3 · Boehringer Ingelheim · Type 2 diabetes, hypertension, cardiovascular disease
  8. 1404-0056 Phase 3 · Boehringer Ingelheim · Obesity

Related patents

Browse patents

  1. US 12258341

    IRAK degraders and uses thereof

    Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12247025

    Processes for preparation of soluble guanylate cyclase stimulators

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12187744

    IRAK4 degraders and synthesis thereof

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12171768

    IRAK4 degraders and uses thereof

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12168057

    IRAK degraders and uses thereof

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12150995

    IRAK degraders and uses thereof

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12097261

    CDK2 degraders and uses thereof

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12091411

    IRAK degraders and uses thereof

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12077555

    STAT degraders and uses thereof

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12006329

    Protein degraders and uses thereof

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11932624

    MDM2 degraders and uses thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11932635

    CRBN ligands and uses thereof

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11858931

    Amino acid compounds with unbranched linkers and methods of use

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11857535

    Methods of treating mutant lymphomas

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11834444

    Processes for preparation of soluble guanylate cyclase stimulators

    Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11807636

    IRAK degraders and uses thereof

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11779578

    IRAK degraders and uses thereof

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11773103

    IRAK4 degraders and uses thereof

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11746120

    Stat degraders and uses thereof

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11731977

    SGC stimulators

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is matching?

matching is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.